As Covid-19 continues to devastate the global economy, DBS Research analyst Yeo Kee Yan and his team have placed their hopes for economic recovery on the successful development of a viable vaccine. With 38 candidates now undergoing clinical evaluations, one or more positive outcomes will be the spark that will fuel ailing economies, they write in a report dated Oct 6.

“Nine months after the first Covid-19 cluster surfaced in China, the world is no closer to containing the pandemic. There are now more than 32 million confirmed cases globally and the figure is rising at a rate of 200,000 to 350,000 new cases per day,” says the team. Six months on from the “great Covid-19 pandemic panic”, how countries manage the virus continues to be a key driver for stock performances today. 

See also: Seeking truth from facts in Covid-19

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook